Please enable JavaScript to continue using this application.

Compare $ARTV vs $PRLD | Chartloom

Compare

$ARTV vs $PRLD

Artiva Biotherapeutics Inc · Prelude Therapeutics Inc

ARTV

Artiva Biotherapeutics Inc

PRLD

Prelude Therapeutics Inc

Compare $ARTV vs $PRLD

Comparing Artiva Biotherapeutics Inc and Prelude Therapeutics Inc

ARTVArtiva Biotherapeutics Inc

PRLDPrelude Therapeutics Inc

ARTVArtiva Biotherapeutics Inc

Market cap

$337M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

64.1%

52W performance

131.3%

FCF yield

-22.8%

PRLDPrelude Therapeutics Inc

Market cap

$310M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.94x

Rev growth (TTM)

—

YTD performance

42.5%

52W performance

173.9%

FCF yield

-10.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARTV

PRLD

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

PRLD

Prelude Therapeutics Inc

Market Cap

ARTV$337M

PRLD$310M

Enterprise Value

ARTV$36M

PRLD$284M

Price

ARTV$6.94

PRLD$3.89

P/E Ratio

ARTVN/A

PRLDN/A

P/S Ratio

ARTV0.00x

PRLD13.82x

EV/Sales

ARTV0.00x

PRLD12.64x

EV/EBITDA

ARTV0.00x

PRLD0.00x

P/B Ratio

ARTV0.96x

PRLD2.19x

P/FCF Ratio

ARTVN/A

PRLDN/A

EV/FCF

ARTV-0.46x

PRLD-8.53x

PEG Ratio

ARTVN/A

PRLDN/A

Forward P/E (NTM)

ARTVN/A

PRLDN/A

Forward P/S (NTM)

ARTVN/A

PRLD5.94x

Revenue (TTM)

ARTV$0

PRLD$22M

Revenue Growth (YoY)

ARTVN/A

PRLDN/A

Forward Rev Growth

ARTV404.4%

PRLD-14.3%

Gross Margin (TTM)

ARTV0.0%

PRLD0.0%

Operating Margin (TTM)

ARTV0.0%

PRLD0.0%

EBITDA Margin (TTM)

ARTV0.0%

PRLD-293.5%

Net Margin (TTM)

ARTV0.0%

PRLD-269.7%

FCF Margin (TTM)

ARTVN/A

PRLD-148.3%

Net Income (TTM)

ARTV$-42M

PRLD$-60M

FCF (TTM)

ARTV$-77M

PRLD$-33M

EPS (TTM)

ARTV$0.00

PRLD-$0.61

ROE (TTM)

ARTV-6022.0%

PRLD-7535.0%

ROA (TTM)

ARTV-5238.0%

PRLD-4439.0%

ROIC (TTM)

ARTV-6019.0%

PRLD-7535.0%

Cash

ARTV$301M

PRLD$26M

Debt

ARTV$0

PRLD$0

Net Cash/Debt

ARTV$301M

PRLD$26M

Current Ratio (TTM)

ARTV24.16x

PRLD4.07x

Quick Ratio (TTM)

ARTV23.97x

PRLD3.99x

Debt/Equity (TTM)

ARTV0.00x

PRLD0.00x

Debt/Assets (TTM)

ARTV0.0%

PRLD0.0%

Interest Coverage (TTM)

ARTVN/A

PRLDN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

PRLD0.00x

Beta

ARTV5.80

PRLD1.19

52W Performance

ARTV131.3%

PRLD173.9%

YTD Performance

ARTV64.1%

PRLD42.5%

% from 52W High

ARTV-52.2%

PRLD-43.0%

% from 52W Low

ARTV156.1%

PRLD238.3%

Asset Turnover (TTM)

ARTV0.00x

PRLD0.16x

FCF Yield (TTM)

ARTV-22.8%

PRLD-10.7%

Earnings Yield (TTM)

ARTV-12.5%

PRLD-19.5%

Dividend Yield (TTM)

ARTVN/A

PRLDN/A

Rule of 40

ARTV0.0

PRLD-148.3

EV/GP/RG

ARTVN/A

PRLDN/A

Ticker research

View ARTV research View PRLD research

Metric	ARTV Artiva Biotherapeutics Inc	PRLD Prelude Therapeutics Inc
Market & Valuation
Market Cap	$337M	$310M
Enterprise Value	$36M	$284M
Price	$6.94	$3.89
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	13.82x
EV/Sales	0.00x	12.64x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.96x	2.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-8.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.94x
Revenue & Growth
Revenue (TTM)	$0	$22M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	404.4%	-14.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-293.5%
Net Margin (TTM)	0.0%	-269.7%
FCF Margin (TTM)	N/A	-148.3%
Net Income (TTM)	$-42M	$-60M
FCF (TTM)	$-77M	$-33M
EPS (TTM)	$0.00	-$0.61
ROE (TTM)	-6022.0%	-7535.0%
ROA (TTM)	-5238.0%	-4439.0%
ROIC (TTM)	-6019.0%	-7535.0%
Financial Health
Cash	$301M	$26M
Debt	$0	$0
Net Cash/Debt	$301M	$26M
Current Ratio (TTM)	24.16x	4.07x
Quick Ratio (TTM)	23.97x	3.99x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	1.19
52W Performance	131.3%	173.9%
YTD Performance	64.1%	42.5%
% from 52W High	-52.2%	-43.0%
% from 52W Low	156.1%	238.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.16x
FCF Yield (TTM)	-22.8%	-10.7%
Earnings Yield (TTM)	-12.5%	-19.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-148.3
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View PRLD research

Valuation

P/S Ratio

ARTV

0.00x

PRLD

13.82x

EV/FCF

PRLD

-8.53x

ARTV

-0.46x

Growth & revenue

Forward Revenue Growth

ARTV

404.4%

PRLD

-14.3%

Profitability & performance

Gross Margin

ARTV

0.0%

PRLD

0.0%

ROE

ARTV

-6022.0%

PRLD

-7535.0%

FCF Yield %

PRLD

-10.7%

ARTV

-22.8%

52-Week Performance

PRLD

173.9%

ARTV

131.3%

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

PRLD

Prelude Therapeutics Inc

Market Cap

ARTV$337M

PRLD$310M

Enterprise Value

ARTV$36M

PRLD$284M

Price

ARTV$6.94

PRLD$3.89

P/E Ratio

ARTVN/A

PRLDN/A

P/S Ratio

ARTV0.00x

PRLD13.82x

EV/Sales

ARTV0.00x

PRLD12.64x

EV/EBITDA

ARTV0.00x

PRLD0.00x

P/B Ratio

ARTV0.96x

PRLD2.19x

P/FCF Ratio

ARTVN/A

PRLDN/A

EV/FCF

ARTV-0.46x

PRLD-8.53x

PEG Ratio

ARTVN/A

PRLDN/A

Forward P/E (NTM)

ARTVN/A

PRLDN/A

Forward P/S (NTM)

ARTVN/A

PRLD5.94x

Revenue (TTM)

ARTV$0

PRLD$22M

Revenue Growth (YoY)

ARTVN/A

PRLDN/A

Forward Rev Growth

ARTV404.4%

PRLD-14.3%

Gross Margin (TTM)

ARTV0.0%

PRLD0.0%

Operating Margin (TTM)

ARTV0.0%

PRLD0.0%

EBITDA Margin (TTM)

ARTV0.0%

PRLD-293.5%

Net Margin (TTM)

ARTV0.0%

PRLD-269.7%

FCF Margin (TTM)

ARTVN/A

PRLD-148.3%

Net Income (TTM)

ARTV$-42M

PRLD$-60M

FCF (TTM)

ARTV$-77M

PRLD$-33M

EPS (TTM)

ARTV$0.00

PRLD-$0.61

ROE (TTM)

ARTV-6022.0%

PRLD-7535.0%

ROA (TTM)

ARTV-5238.0%

PRLD-4439.0%

ROIC (TTM)

ARTV-6019.0%

PRLD-7535.0%

Cash

ARTV$301M

PRLD$26M

Debt

ARTV$0

PRLD$0

Net Cash/Debt

ARTV$301M

PRLD$26M

Current Ratio (TTM)

ARTV24.16x

PRLD4.07x

Quick Ratio (TTM)

ARTV23.97x

PRLD3.99x

Debt/Equity (TTM)

ARTV0.00x

PRLD0.00x

Debt/Assets (TTM)

ARTV0.0%

PRLD0.0%

Interest Coverage (TTM)

ARTVN/A

PRLDN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

PRLD0.00x

Beta

ARTV5.80

PRLD1.19

52W Performance

ARTV131.3%

PRLD173.9%

YTD Performance

ARTV64.1%

PRLD42.5%

% from 52W High

ARTV-52.2%

PRLD-43.0%

% from 52W Low

ARTV156.1%

PRLD238.3%

Asset Turnover (TTM)

ARTV0.00x

PRLD0.16x

FCF Yield (TTM)

ARTV-22.8%

PRLD-10.7%

Earnings Yield (TTM)

ARTV-12.5%

PRLD-19.5%

Dividend Yield (TTM)

ARTVN/A

PRLDN/A

Rule of 40

ARTV0.0

PRLD-148.3

EV/GP/RG

ARTVN/A

PRLDN/A

Ticker research

View ARTV research View PRLD research

Metric	ARTV Artiva Biotherapeutics Inc	PRLD Prelude Therapeutics Inc
Market & Valuation
Market Cap	$337M	$310M
Enterprise Value	$36M	$284M
Price	$6.94	$3.89
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	13.82x
EV/Sales	0.00x	12.64x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.96x	2.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-8.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.94x
Revenue & Growth
Revenue (TTM)	$0	$22M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	404.4%	-14.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-293.5%
Net Margin (TTM)	0.0%	-269.7%
FCF Margin (TTM)	N/A	-148.3%
Net Income (TTM)	$-42M	$-60M
FCF (TTM)	$-77M	$-33M
EPS (TTM)	$0.00	-$0.61
ROE (TTM)	-6022.0%	-7535.0%
ROA (TTM)	-5238.0%	-4439.0%
ROIC (TTM)	-6019.0%	-7535.0%
Financial Health
Cash	$301M	$26M
Debt	$0	$0
Net Cash/Debt	$301M	$26M
Current Ratio (TTM)	24.16x	4.07x
Quick Ratio (TTM)	23.97x	3.99x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	1.19
52W Performance	131.3%	173.9%
YTD Performance	64.1%	42.5%
% from 52W High	-52.2%	-43.0%
% from 52W Low	156.1%	238.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.16x
FCF Yield (TTM)	-22.8%	-10.7%
Earnings Yield (TTM)	-12.5%	-19.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-148.3
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View PRLD research